insights_auto
Why is M1RN34 up 5,19%?
Dive Deeperchevron_right
M1RN34:BVMF
Moderna Inc Bdr
49,07 BRL
arrow_upward
+5,19%(+2,42) 1D
7-окт., 17:06:00 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for M1RN34...
Open
45,99 BRL
High
49,49 BRL
Low
45,65 BRL
Mkt. cap
78,44 млд
Avg. vol.
114,33 миң
Volume
144,15 миң
52-wk high
54,38 BRL
52-wk low
6,02 BRL
Shares outstanding
399,24 млн
No. of employees
5 миң
Open
45,99 BRL
High
49,49 BRL
Low
45,65 BRL
Mkt. cap
78,44 млд
Avg. vol.
114,33 миң
Volume
144,15 миң
52-wk high
54,38 BRL
52-wk low
6,02 BRL
Shares outstanding
399,24 млн
No. of employees
5 миң
News stories
From web sources and news partners
GuruFocus
·
29 мүнөт мурун
Moderna (MRNA) Shares Rise 4.8% Despite Broad Market Weakness on October 7, 2026
Investing.com Canada
·
1 саат мурун
Form 4 Moderna Inc For: 7 October By Investing.com
Investopedia
·
1 саат мурун
Moderna, Eli Lilly Lead Healthcare Stocks Higher on a Down Day for Markets
Timothy Sykes
·
2 саат мурун
MRNA Stock Jumps As Nasdaq-100 Inclusion Ignites Momentum
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
About Moderna Inc Bdr